Michael Lanuti

20.9k total citations · 2 hit papers
187 papers, 5.4k citations indexed

About

Michael Lanuti is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Michael Lanuti has authored 187 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Pulmonary and Respiratory Medicine, 52 papers in Surgery and 47 papers in Oncology. Recurrent topics in Michael Lanuti's work include Lung Cancer Diagnosis and Treatment (68 papers), Lung Cancer Treatments and Mutations (46 papers) and Medical Imaging and Pathology Studies (24 papers). Michael Lanuti is often cited by papers focused on Lung Cancer Diagnosis and Treatment (68 papers), Lung Cancer Treatments and Mutations (46 papers) and Medical Imaging and Pathology Studies (24 papers). Michael Lanuti collaborates with scholars based in United States, China and Germany. Michael Lanuti's co-authors include Douglas J. Mathisen, Cameron D. Wright, John C. Wain, Henning A. Gaissert, Bryan C. Fuchs, Kenneth K. Tanabe, Dean M. Donahue, Jo-Anne O. Shepard, Jonathan M. Goodwin and Tsutomu Fujii and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and JAMA.

In The Last Decade

Michael Lanuti

179 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial

2020 425 citations Michael Lanuti et al. profile →
Deep learning classification of lung cancer histology using CT images

2021 163 citations Michael Lanuti, David C. Christiani et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Lanuti United States	41	3.3k	1.6k	1.3k	745	677	187	5.4k
Salma K. Jabbour United States	33	2.1k 0.6×	2.1k 1.3×	853 0.7×	979 1.3×	503 0.7×	244	4.3k
Matthew J. Schipper United States	39	2.7k 0.8×	1.1k 0.7×	1.1k 0.8×	1.8k 2.4×	620 0.9×	235	6.0k
Norihiko Ikeda Japan	43	4.5k 1.4×	1.8k 1.1×	1.2k 0.9×	1.1k 1.4×	740 1.1×	346	6.3k
Masato Hareyama Japan	36	3.3k 1.0×	1.6k 0.9×	1.7k 1.4×	1.4k 1.9×	836 1.2×	178	6.2k
Kenichi Yoshimura Japan	33	1.6k 0.5×	1.7k 1.0×	1.2k 1.0×	367 0.5×	680 1.0×	247	4.5k
Maurice Stephan Michel Germany	42	3.6k 1.1×	573 0.3×	1.2k 1.0×	661 0.9×	972 1.4×	285	6.2k
Roy H. Decker United States	39	2.6k 0.8×	2.0k 1.2×	878 0.7×	915 1.2×	780 1.2×	175	4.9k
Jeffrey L. Port United States	39	4.2k 1.3×	1.9k 1.1×	2.3k 1.8×	808 1.1×	748 1.1×	159	6.8k
Lidia Strigari Italy	38	2.3k 0.7×	999 0.6×	667 0.5×	2.2k 2.9×	551 0.8×	282	5.7k
C.A. Reddy United States	52	5.9k 1.8×	1.2k 0.7×	1.5k 1.2×	1.3k 1.7×	737 1.1×	340	9.3k

Countries citing papers authored by Michael Lanuti

Since Specialization

Citations

This map shows the geographic impact of Michael Lanuti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lanuti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lanuti more than expected).

Fields of papers citing papers by Michael Lanuti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lanuti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lanuti. The network helps show where Michael Lanuti may publish in the future.

Co-authorship network of co-authors of Michael Lanuti

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lanuti. A scholar is included among the top collaborators of Michael Lanuti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lanuti. Michael Lanuti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lanuti, Michael, et al.. (2025). Extent of resection for spread-through air spaces−positive stage IA1-2 non−small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery.

Mak, Raymond H., Michael Lanuti, Alona Muzikansky, et al.. (2024). The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC. The Oncologist. 29(7). 609–618. 8 indexed citations

Lee, Mi‐Sun, Ki-Do Eum, Longxiang Li, et al.. (2024). Ambient beta particle radioactivity and lung cancer survival: Results from the Boston Lung Cancer Study. Environmental Research. 264(Pt 1). 120307–120307. 1 indexed citations

Nandy, Sreyankar, Satomi Yamamoto, Jaeyul Lee, et al.. (2024). Microscopic Small Airway Abnormalities Identified in Early Idiopathic Pulmonary Fibrosis In Vivo Using Endobronchial Optical Coherence Tomography. American Journal of Respiratory and Critical Care Medicine. 210(4). 473–483. 7 indexed citations

Cheng, Chao, Xinan Wang, Chongming Jiang, et al.. (2023). Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer. Journal of Thoracic Oncology. 18(9). 1184–1198. 14 indexed citations

Wu, Shaowei, Lintong Yao, Guoqing Liao, et al.. (2023). Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB–IV NSCLC (LCDigital-IO Study): a multicenter retrospective study. Journal for ImmunoTherapy of Cancer. 11(10). e007369–e007369. 20 indexed citations

Potter, Alexandra L., et al.. (2023). Segmentectomy vs Lobectomy for Early Non-Small Cell Lung Cancer With Visceral Pleural Invasion. The Annals of Thoracic Surgery. 117(5). 1007–1014. 10 indexed citations

Ackman, Jeanne B., et al.. (2021). Longitudinal CT and MRI Characteristics of Unilocular Thymic Cysts. Radiology. 301(2). 443–454. 12 indexed citations

Bunck, Alexander C., et al.. (2021). Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study. Annals of Surgical Oncology. 28(11). 5829–5839. 16 indexed citations

10.

Zhou, Haiyu, Shaopeng Zheng, Anlin Li, et al.. (2020). Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study). EClinicalMedicine. 24. 100422–100422. 17 indexed citations

11.

Tapias, Luis F., Cameron D. Wright, Michael Lanuti, et al.. (2019). Hyperbaric oxygen therapy in the prevention and management of tracheal and oesophageal anastomotic complications. European Journal of Cardio-Thoracic Surgery. 57(6). 1203–1209. 8 indexed citations

12.

Pennell, Nathan A., Joel W. Neal, Jamie E. Chaft, et al.. (2018). SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 37(2). 97–104. 137 indexed citations

13.

Ren, Xi, Luis F. Tapias, Bernhard J. Jank, et al.. (2015). Ex vivo non-invasive assessment of cell viability and proliferation in bio-engineered whole organ constructs. Biomaterials. 52. 103–112. 42 indexed citations

14.

Manley, Christopher, Lida P. Hariri, David C. Adams, et al.. (2015). Optical Coherence Tomography Imaging for the Diagnosis of Airway Tumors In Vivo. CHEST Journal. 148(4). 561A–561A. 1 indexed citations

15.

Tapias, Luis F., Olaf Mercier, Maria‐Rosa Ghigna, et al.. (2014). Validation of a Scoring System to Predict Recurrence of Resected Solitary Fibrous Tumors of the Pleura. CHEST Journal. 147(1). 216–223. 38 indexed citations

16.

Caravan, Peter, Yan Yang, Anthony D. Schmitt, et al.. (2013). Molecular Magnetic Resonance Imaging of Pulmonary Fibrosis in Mice. American Journal of Respiratory Cell and Molecular Biology. 49(6). 1120–1126. 82 indexed citations

17.

Lanuti, Michael, Christopher R. Morse, Cameron D. Wright, et al.. (2011). Management of Delayed Gastric Emptying After Esophagectomy With Endoscopic Balloon Dilatation of the Pylorus. The Annals of Thoracic Surgery. 91(4). 1019–1024. 42 indexed citations

18.

Gaissert, Henning A., Cameron D. Wright, Marek Ancukiewicz, et al.. (2009). POINT: Operative risk of pneumonectomy—Influence of preoperative induction therapy. Journal of Thoracic and Cardiovascular Surgery. 138(2). 289–294. 22 indexed citations

19.

Fujii, Tsutomu, Bryan C. Fuchs, Gregory Y. Lauwers, et al.. (2008). Mouse model of CCl4-induced HCC: histopathological changes and expression of EGF and CD133. Cancer Research. 68. 2954–2954.

20.

Morse, Christopher R., William G. Austen, Henning A. Gaissert, et al.. (2008). Surgical management of failed colon interposition☆. European Journal of Cardio-Thoracic Surgery. 34(2). 432–437. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact